Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Patients were very satisfied with the multidisciplinary group visit for alopecia areata.

Dihydroartemisinin could be a versatile cosmetic ingredient but needs more research and development.

The document corrected previous errors and announced future dermatology events.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Older Julia Creek dunnarts often have reproductive and hormonal health issues.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Squaric acid dibutylester effectively treats alopecia areata.

The hydrogel dressing speeds up and improves diabetic wound healing.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The Seoul International Dermatology Symposium was a successful event that highlighted new dermatology treatments and fostered international relations.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

ODC transgenic mice can model human hair loss with skin lesions.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.